This content is machine translated Atopic dermatitis and the skin microbiome How does systemic therapy influence dysbiosis? One aim of the multicenter observational study ProRaD is to gain a better understanding of the mechanisms that influence the course of atopic dermatitis (AD). In a sub-project, researchers used…
View Post 7 min This content is machine translated Biologics for AD Interleukin-13 as a target – new long-term data available Now that the range of systemic therapeutics for atopic dermatitis has been expanded and the two monoclonal antibodies dupilumab and tralokinumab as well as three Janus kinase inhibitors have been…
View Post 5 min This content is machine translated Psoriatic Arthritis Multidimensional and multidisciplinary management If psoriatic arthritis is not adequately treated in good time, it can lead to permanent deformities and functional limitations. A broad armamentarium of evidence-based effective systemic therapeutics is available for…
View Post 8 min This content is machine translated Psoriasis The era of biologics – a tour d’horizon through significant research decades The development of highly effective biologics was preceded by research efforts over several decades. Advances in immunopathogenetic and molecular genetic analyses contributed significantly to the generation of these innovative system…
View Post 6 min This content is machine translated Atopic dermatitis Modern systems therapeutics specifically regulate the excessive immune response The therapeutic landscape for patients with moderate to severe atopic dermatitis is changing. In the multifactorial pathogenesis of this chronic recurrent dermatosis, an impaired immune response plays a central role.…
